NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 2, 2026 Bullish $0.219 V 1
Dec 23, 2025 $1.93 +4.88% $1.86 V 96.24% 1
Dec 23, 2025 $1.90 +3.05% $1.86 V 98.06% 1
Dec 23, 2025 Bullish $1.86 V 1
Nov 21, 2025 $1.81 -3.67% $1.88 X 96.33% 0
Nov 21, 2025 $1.84 -2.30% $1.88 X 97.70% 0
Nov 21, 2025 Bullish $1.88 X 0
Aug 29, 2025 $1.25 +14.68% $0.85 X 53.15% 0
Aug 28, 2025 $2.50 +5.06% $1.09 X 0.00% 0
Aug 28, 2025 $2.45 +3.16% $1.09 X 0.00% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE